PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL • Segmentation by distribution channel • Comparison by distribution channel • Retail stores • Online stores • Market opportunity by distribution channel PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas– Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Importance of family planning • Advent of online apps • Rising disposable income PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • LUPIN • Mankind Pharma • Perrigo • Piramal Enterprises • Sun Pharmaceutical Industries PART 15: APPENDIX • List of abbreviations   Exhibit 01: Parent market Exhibit 02: Global female contraceptive market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global emergency contraceptive pill 2017-2022 ($ mn) Exhibit 09: Global emergency contraceptive pill market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Global emergency contraceptive pill market by distribution channel – Market share 2017-2022 (%) Exhibit 19: Comparison by distribution channel Exhibit 20: Retail stores – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Retail stores – Year-over-year growth 2018-2022 (%) Exhibit 22: Online stores – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Online stores – Year-over-year growth 2018-2022 (%) Exhibit 24: Market opportunity by distribution channel Exhibit 25: Customer landscape Exhibit 26: Global emergency contraceptive pill market by geography – Market share 2017-2022 (%) Exhibit 27: Regional comparison Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 29: Americas – Year-over-year growth 2018-2022 (%) Exhibit 30: Top three countries in Americas Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 32: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 33: Top three countries in EMEA Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 35: APAC – Year-over-year growth 2018-2022 (%) Exhibit 36: Top three countries in APAC Exhibit 37: Market opportunity Exhibit 38: Vendor landscape Exhibit 39: Landscape disruption Exhibit 40: Vendors covered Exhibit 41: Vendor classification Exhibit 42: Market positioning of vendors Exhibit 43: LUPIN overview Exhibit 44: LUPIN – Business segments Exhibit 45: LUPIN– Organizational developments Exhibit 46: LUPIN– Geographic focus Exhibit 47: LUPIN – Key offerings Exhibit 48: Mankind Pharma overview Exhibit 49: Mankind Pharma – Business segments Exhibit 50: Mankind Pharma – Organizational developments Exhibit 51: Mankind Pharma – Segment focus Exhibit 52: Mankind Pharma – Key offerings Exhibit 53: Perrigo overview Exhibit 54: Perrigo– Business segments Exhibit 55: Perrigo– Organizational developments Exhibit 56: Perrigo– Geographic focus Exhibit 57: Perrigo– Segment focus Exhibit 58: Perrigo– Key offerings Exhibit 59: Piramal Enterprises overview Exhibit 60: Piramal Enterprises– Business segments Exhibit 61: Piramal Enterprises– Organizational developments Exhibit 62: Piramal Enterprises– Geographic focus Exhibit 63: Piramal Enterprises– Segment focus Exhibit 64: Piramal Enterprises– Key offerings Exhibit 65: Sun Pharmaceutical Industries overview Exhibit 66: Sun Pharmaceutical Industries– Business segments Exhibit 67: Sun Pharmaceutical Industries– Organizational developments Exhibit 68: Sun Pharmaceutical Industries– Geographic focus Exhibit 69: Sun Pharmaceutical Industries– Segment focus Exhibit 70: Sun Pharmaceutical Industries– Key offerings

LUPIN Mankind Pharma Perrigo Piramal Enterprises Sun Pharmaceutical Industries